New Delhi, May 25 (PTI) Aurobindo Pharma on Saturday reported a 79.6 per cent increase in consolidated net profit at Rs 909 crore for the March quarter.

The drug firm had reported a net profit of Rs 506 crore in the January-March quarter of the FY23 fiscal.

Also Read | Nautapa 2024 Date and Time: Know the Meaning of Nautapa, Which Marks the Hottest Nine Days of the Year in Summer.

Revenue from operations rose to Rs 7,580 crore in the period under review as compared with Rs 6,473 crore in the year-ago period, Aurobindo Pharma said in a statement.

For the financial year ended March 31, 2024, the drugmaker reported a net profit of Rs 3,173 crore as against Rs 1,927 crore in FY23.

Also Read | Lok Sabha Elections 2024: How To Vote, Check Name in Voter List and Download Voter Slip Online? How To Find Polling Station? Know Everything Here Ahead of Phase 6 Polling on May 25.

The company's revenue from operations rose to Rs 29,002 crore in the last fiscal as against Rs 24,855 crore in FY23.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)